NO941561D0 - - Google Patents

Info

Publication number
NO941561D0
NO941561D0 NO941561A NO941561A NO941561D0 NO 941561 D0 NO941561 D0 NO 941561D0 NO 941561 A NO941561 A NO 941561A NO 941561 A NO941561 A NO 941561A NO 941561 D0 NO941561 D0 NO 941561D0
Authority
NO
Norway
Prior art keywords
urokinase variants
bifunctional urokinase
polypeptides
active ingredient
production
Prior art date
Application number
NO941561A
Other languages
English (en)
Norwegian (no)
Other versions
NO941561L (no
Original Assignee
Gruenenthal Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie
Publication of NO941561D0 publication Critical patent/NO941561D0/no
Publication of NO941561L publication Critical patent/NO941561L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6462—Plasminogen activators u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21073—Serine endopeptidases (3.4.21) u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO941561A 1993-07-15 1994-04-28 Bifunksjonelle urokinasevarianter med forbedrede fibrinolytiske egenskaper og trombinhemmende virkning NO941561L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4323754A DE4323754C1 (de) 1993-07-15 1993-07-15 Bifunktionelle Urokinasevarianten mit verbesserten fibrinolytischen Eigenschaften und thrombinhemmender Wirkung

Publications (2)

Publication Number Publication Date
NO941561D0 true NO941561D0 (Direct) 1994-04-28
NO941561L NO941561L (no) 1995-01-16

Family

ID=6492909

Family Applications (1)

Application Number Title Priority Date Filing Date
NO941561A NO941561L (no) 1993-07-15 1994-04-28 Bifunksjonelle urokinasevarianter med forbedrede fibrinolytiske egenskaper og trombinhemmende virkning

Country Status (26)

Country Link
US (2) US5681721A (Direct)
EP (1) EP0669394B1 (Direct)
JP (1) JPH07143878A (Direct)
KR (1) KR960014346A (Direct)
CN (1) CN1057124C (Direct)
AT (1) ATE189261T1 (Direct)
AU (1) AU679512B2 (Direct)
CA (1) CA2127897A1 (Direct)
CZ (1) CZ288536B6 (Direct)
DE (2) DE4323754C1 (Direct)
DK (1) DK0669394T3 (Direct)
ES (1) ES2145075T3 (Direct)
FI (1) FI943354L (Direct)
GR (1) GR3032488T3 (Direct)
HR (1) HRP940366B1 (Direct)
HU (1) HU217101B (Direct)
IL (1) IL109107A0 (Direct)
NO (1) NO941561L (Direct)
NZ (1) NZ260991A (Direct)
PL (1) PL176971B1 (Direct)
PT (1) PT669394E (Direct)
RU (1) RU2143490C1 (Direct)
SI (1) SI0669394T1 (Direct)
SK (1) SK281586B6 (Direct)
UA (1) UA27132C2 (Direct)
ZA (1) ZA944202B (Direct)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4440892A1 (de) * 1994-11-17 1996-05-23 Gruenenthal Gmbh Proteine mit fibrinolytischen und gerinnungshemmenden Eigenschaften
DE4442665A1 (de) * 1994-11-30 1996-06-05 Gruenenthal Gmbh Chimäre Proteine mit fibrinolytischen und thrombinhemmenden Eigenschaften
CN1057125C (zh) * 1996-04-26 2000-10-04 南京大学 五种尿激酶变体基因及在大肠杆菌中的表达
CN1111739C (zh) * 1997-02-04 2003-06-18 许文俊 凝血、纤溶功能动态测定试剂
US6503947B1 (en) 1998-01-27 2003-01-07 Brigham And Women's Hospital Method of treating cytotoxic damage
US7498310B1 (en) 1998-08-13 2009-03-03 Beiersdorf Ag Cosmetic or dermatological preparations comprising oligopeptides for lightening the skin of age marks and/or for preventing tanning of the skin, in particular tanning of the skin caused by UV radiation
AU2001269803A1 (en) * 2000-06-20 2002-01-02 The Trustees Of The University Of Pennsylvania Compositions and methods for modulating muscle cell and tissue contractility
US7361493B1 (en) 2004-05-26 2008-04-22 The United States Of America As Represented By The Secretary Of The Department Of Veterans Affairs Production of urokinase in a three-dimensional cell culture
CN102225966B (zh) 2004-10-19 2012-12-26 隆萨股份公司 用于固相肽合成的方法
CN104193807B (zh) * 2014-09-28 2016-06-15 广州贝奥吉因生物科技有限公司 凝血酶抑制多肽及其制备方法、应用
CN105385617A (zh) * 2015-09-23 2016-03-09 河北省科学院生物研究所 一株产纤溶酶的海洋放线菌株、用途以及由其制备的纤溶酶及纤溶酶的应用
JP2020501561A (ja) 2016-12-16 2020-01-23 ザ・ユニバーシティ・オブ・シドニー 脳卒中および関係する凝固性障害の処置のためのトロンビン阻害剤

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3930944A (en) * 1975-03-31 1976-01-06 Abbott Laboratories Urokinase production
DE3445517C2 (de) * 1984-12-13 1993-11-18 Ciba Geigy Für ein Hirudin-ähnliches Protein codierende DNA-Sequenz und Verfahren zur Herstellung eines Hirudin-ähnlichen Proteins
US4751180A (en) * 1985-03-28 1988-06-14 Chiron Corporation Expression using fused genes providing for protein product
US5002887A (en) * 1986-01-31 1991-03-26 Genetics Institute, Inc. Truncated thrombolytic proteins
WO1989001513A1 (fr) * 1987-08-19 1989-02-23 Sagami Chemical Research Center Prourokinase a action rapide
DE3804600A1 (de) * 1988-02-13 1989-08-24 Basf Ag Mischung aus einer thrombolytisch wirkenden und einer antithrombotischen substanz
GB8822147D0 (en) * 1988-09-21 1988-10-26 Ciba Geigy Ag Pharmaceutically active combination
US5256770A (en) * 1990-04-09 1993-10-26 Schering Ag Oxidation resistant thrombomodulin analogs
EP0482069A1 (en) * 1989-07-20 1992-04-29 Biogen, Inc. Combinations and methods for treating or preventing thrombotic diseases
GB8927722D0 (en) * 1989-12-07 1990-02-07 British Bio Technology Proteins and nucleic acids
US5328898A (en) * 1990-06-22 1994-07-12 Duke University Factor XIIIA fibrin binding fragments
GB9015369D0 (en) * 1990-07-12 1990-08-29 Erba Carlo Spa Amidated fibrinolytic enzymes and their precursors,and processes for their preparation
US5242810A (en) * 1990-12-07 1993-09-07 Biogen, Inc. Bifunctional inhibitors of thrombin and platelet activation
US5688768A (en) * 1991-02-19 1997-11-18 Cor Therapeutics, Inc. Recombinant thrombin receptor and related pharmaceuticals
AU1873092A (en) * 1991-04-09 1992-11-17 Brigham And Women's Hospital Chimeric molecule with plasminogen activator activity and affinity for atherosclerotic plaques
US5376367A (en) * 1991-11-22 1994-12-27 Immunex Corporation Fusion proteins comprising MGF and IL-3
US5571708A (en) * 1993-04-19 1996-11-05 Bristol-Myers Squibb Company Thrombin-activatable plasminogen activator
RU2061043C1 (ru) * 1993-11-16 1996-05-27 Научно-производственная фирма "Нарт" Способ повышения устойчивости урокиназы к нагреванию

Also Published As

Publication number Publication date
RU94026095A (ru) 1997-03-10
UA27132C2 (uk) 2000-02-28
PL176971B1 (pl) 1999-08-31
DE59409104D1 (de) 2000-03-02
ATE189261T1 (de) 2000-02-15
US5747291A (en) 1998-05-05
SI0669394T1 (en) 2000-04-30
FI943354A7 (fi) 1995-01-16
US5681721A (en) 1997-10-28
SK281586B6 (sk) 2001-05-10
HK1010109A1 (en) 1999-06-11
EP0669394B1 (de) 2000-01-26
PL304290A1 (en) 1995-01-23
ZA944202B (en) 1995-02-08
NZ260991A (en) 1995-10-26
FI943354L (fi) 1995-01-16
NO941561L (no) 1995-01-16
CA2127897A1 (en) 1995-01-16
AU6452594A (en) 1995-01-27
RU2143490C1 (ru) 1999-12-27
GR3032488T3 (en) 2000-05-31
HU9402063D0 (en) 1994-09-28
CZ170694A3 (en) 1995-02-15
KR960014346A (ko) 1996-05-22
ES2145075T3 (es) 2000-07-01
HRP940366B1 (en) 2001-02-28
HU217101B (hu) 1999-11-29
DK0669394T3 (da) 2000-05-29
AU679512B2 (en) 1997-07-03
CN1102438A (zh) 1995-05-10
HUT70579A (en) 1995-10-30
EP0669394A1 (de) 1995-08-30
FI943354A0 (fi) 1994-07-14
DE4323754C1 (de) 1994-12-01
IL109107A0 (en) 1994-06-24
CN1057124C (zh) 2000-10-04
SK84594A3 (en) 1995-03-08
CZ288536B6 (cs) 2001-07-11
JPH07143878A (ja) 1995-06-06
HRP940366A2 (en) 1997-04-30
PT669394E (pt) 2000-07-31

Similar Documents

Publication Publication Date Title
IL61408A (en) Enzyme derivatives comprising binary complexes between streptokinase and plasminogen,their preparation and pharmaceutical compositions containing them
ES8802442A1 (es) Un procedimiento para preparar un polimero de adn.
NO964966D0 (no) Lactobacillusstammer av human opprinnelse, blandinger samt anvendelse derav
AU4443893A (en) Peptides capable of inhibiting the activity of HIV protease, their preparation and their use
NO941561D0 (Direct)
IL80659A (en) Modified tissue plasminogen activators,their preparation and pharmaceutical compositions containing them
AU6682594A (en) Treatment of septic shock
EP1825864A3 (en) Antithrombotic agents
MY105128A (en) Bu-3608 derivatives.
AU2001251655A1 (en) Cytokine uses; compositions; methods
EP0208785A4 (en) FIBRINOPHILER UROKINASE COMPLEX AND THEIR PRODUCTION.
HK11891A (en) Naphthoxazines
CA2007075A1 (en) New thrombolytic compositions
AU647763B2 (en) Combined preparation with thrombolytic action
WO1991019793A3 (en) Hybrid plasminogen activators
IT1254452B (it) N-ossidi ed n,n'-diossidi di 3-(piperazin-1-il)-propan-1,2-dioli
YU44594A (sh) Bifunkcionalne varijante urokinaze sa poboljšanim fibrinolitskim svojstvima i delovanjem na suzbijanju trombina
ATE100330T1 (de) Plasminogenaktivator und thrombolytischer wirkstoff.
ZA942972B (en) New quinoxalinedione derivatives, their production and use in pharmaceutical agents.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application